Lixte Biotechnology Files 8-K
Ticker: LIXT · Form: 8-K · Filed: May 20, 2024 · CIK: 1335105
| Field | Detail |
|---|---|
| Company | Lixte Biotechnology Holdings, INC. (LIXT) |
| Form Type | 8-K |
| Filed Date | May 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, regulatory-filing
Related Tickers: LIXT
TL;DR
LIXT filed an 8-K on 5/20, but it's mostly procedural with no juicy details yet.
AI Summary
Lixte Biotechnology Holdings, Inc. filed an 8-K on May 20, 2024, reporting other events and financial statements. The company, incorporated in Delaware, has its principal executive offices in Pasadena, California. This filing does not appear to contain specific transactional details or financial figures beyond the reporting date.
Why It Matters
This filing indicates Lixte Biotechnology Holdings, Inc. has made a regulatory submission, but it lacks specific details about the nature of the events or financial information reported.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting events and financial statements, with no immediate indication of significant financial or operational changes.
Key Players & Entities
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (company) — Filer
- May 20, 2024 (date) — Date of earliest event reported
- 001-39717 (company) — Commission File Number
- 20-2903526 (company) — IRS Employer Identification No.
FAQ
What specific events are being reported in this 8-K filing?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as items being reported, but the provided text does not detail the specific nature of these events.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on May 20, 2024.
What is Lixte Biotechnology Holdings, Inc.'s Commission File Number?
Lixte Biotechnology Holdings, Inc.'s Commission File Number is 001-39717.
Where are Lixte Biotechnology Holdings, Inc.'s principal executive offices located?
Lixte Biotechnology Holdings, Inc.'s principal executive offices are located at 680 East Colorado Boulevard, Suite 180, Pasadena, California 91101.
What is the IRS Employer Identification Number for Lixte Biotechnology Holdings, Inc.?
The IRS Employer Identification Number for Lixte Biotechnology Holdings, Inc. is 20-2903526.
Filing Stats: 360 words · 1 min read · ~1 pages · Grade level 12.6 · Accepted 2024-05-20 17:05:28
Filing Documents
- form8-k.htm (8-K) — 35KB
- ex99-1.htm (EX-99.1) — 22KB
- 0001493152-24-020752.txt ( ) — 271KB
- lixt-20240520.xsd (EX-101.SCH) — 3KB
- lixt-20240520_def.xml (EX-101.DEF) — 26KB
- lixt-20240520_lab.xml (EX-101.LAB) — 36KB
- lixt-20240520_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 20, 2024 LIXTE BIOTECHNOLOGY HOLDINGS, INC. By: /s/ BASTIAAN VAN DER BAAN Bastiaan van der Baan President and Chief Executive Officer 2 INDEX TO EXHIBITS Exhibit No. Description 99.1 Press release providing an update on the Company's recent activities, including notable pre-clinical developments 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) 3